OTCM
LTGHF
Market cap1.08bUSD
, Last price
Name
Life Healthcare Group Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Johannesburg, South Africa, Life Healthcare Group Holdings Limited, established in 1983, operates as a prominent international provider of private hospital services. Its extensive operations span South Africa, Canada, the United Kingdom, various other European countries, and broader international markets. The company's business is structured into two principal divisions: Hospitals and Complementary Services, and Healthcare Services. It delivers a comprehensive range of acute hospital care alongside diverse complementary offerings. These include the specialized services of Life Esidimeni, which covers chronic mental healthcare, frail care, rehabilitation, step-down facilities, correctional healthcare, primary care, and substance abuse recovery programs. Additionally, its Life Employee Health Solutions segment provides on-site occupational health, primary healthcare, and employee wellness initiatives. The company's medical expertise extends across numerous fields, such as diagnostics, mental health treatment, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedics, pediatrics, dermatology, ophthalmology, gynecology, and obstetrics. Furthermore, Life Healthcare is involved in advanced diagnostic imaging, operating magnetic resonance imaging (MRI) and computerized tomography (CT) scanners, and both developing and distributing radiopharmaceuticals vital for positron emission tomography-computerized tomography (PET-CT) diagnostics. The organization was formerly known as Afrox Healthcare Limited until its name change to Life Healthcare Group Holdings Limited in January 2005.
Related entities
Subsidiaries
Life Healthcare Funding Limited
Key people
Victor Litlhakanyane
Independent Non-Executive Chairman of the Board · since 2021
Peter Wharton-Hood
Group Chief Executive, Executive Director · since 2020
Craig Koekemoer
Chief Operations Officer · since 2024
Avanthi Parboosing
Chief People Officer · since 2021
David Price
Chief Information Officer · since 2024
Pieter Van Der Westhuizen
Group Chief Financial Officer, Executive Director · since 2020
Andre Joseph
Funders and Health Policy Executive · since 2025
Brett Mill
Chief Actuary and Risk Officer · since 2024
Asanda Myataza
Finance Executive · since 2024
Pennie Phillips
Marketing and Communications, Change and Life Health Solutions Executive · since 2024
Adam Pyle
Chief Strategy and Growth Officer · since 2024
Merle Victor
Chief Nurse Officer · since 2024
Kurt Wylie
New Business Executive · since 2024
Joshila Ranchhod
Group Company Secretary · since 2021
Lead Independent Non-Executive Director · since 2023
Fareed Abdullah
Independent Non-Executive Director · since 2024
Jeanne Bolger
Independent Non-Executive Director · since 2022
Raymond Campbell
Independent Non-Executive Director · since 2024
Independent Non-Executive Director · since 2021
Paul Moeketsi
Independent Non-Executive Director · since 2023
Headquarters & legal address
21 OXFORD, MANOR RUDD AND CHAPLIN ROADS
Illovo, KZN 2196
ZA
Illovo, KZN 2196
ZA
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||